drugset / Trial / NCT04187417

Short Term Topical Tetracaine is Safe and Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions

NCT04187417 ↗

Completed 118 enrolled INTEGRIS Southwest Medical Center
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The objective of this study was to show that patients with corneal abrasions would experience more pain relief with short term topical tetracaine than placebo, have similar complication rates, and take less hydrocodone for breakthrough pain.

Timeline

Start
2015-01-01
Primary completion
2017-09-30
Completion
2018-09-30

Outcome

Met primary endpoint

paper the overall numeric rating scale pain score after use of the study drops was significantly lower in the tetracaine group (1) versus placebo group (8) PMID 33121832 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject tetracaine Other / unclassified 1 % Topical

Indications